If you plan to invest in the Indian Pharma sector, you have chosen the right sector, as the Pharma sector is expected to grow from $65 billion in 2024 to $130 billion by 2030. An excellent opportunity awaits investors. However, if you need to pick stocks for long term to get impressive returns. Here are some pharma sector stocks investors may consider for long-term investments (not investment advice):

Aurobindo Pharma: The company works with generic drugs, active pharmaceutical ingredients (APIs), and formulations. They have a strong presence in the US generics market, extensive product portfolio, and cost-effective manufacturing.

Divi’s Laboratories: The company's core business is manufacturing APIs and intermediates for pharmaceutical companies worldwide. They have strong R&D capabilities, backward integration, and focus on complex molecules.

Sun Pharmaceuticals: It is India's largest pharmaceutical company, with a strong presence in domestic and international markets. They have a diversified product portfolio, strong R&D capabilities, and a focus on specialty drugs.

Cipla: They specialize in Respiratory drugs, anti-retroviral drugs, and oncology products. Cipla has a strong presence in emerging markets, a focus on affordable healthcare, and a robust distribution network.

Please note that the past performance does not guarantee future returns. You need to do a detailed analysis to find the best long term stocks. On top of it, once you buy the stock, you need to continuously monitor the stocks in your portfolio. The good news is that this can be taken care of by artificial intelligence. Check Jarvis Invest for more details on how to pick artificial intelligence stocks in India.

Let us know in the comments which pharma stock you have in your portfolio.